In today’s recent session, 1.04 million shares of the Nuvation Bio Inc (NYSE:NUVB) have been traded, and its beta is 1.47. Most recently the company’s share price was $1.82, and it changed around $0.0 or -0.27% from the last close, which brings the market valuation of the company to $612.68M. NUVB at last check was trading at a discount to its 52-week high of $4.16, offering almost -128.57% off that amount. The share price’s 52-week low was $1.67, which indicates that the recent value has risen by an impressive 8.24% since then.
Nuvation Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended NUVB as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Nuvation Bio Inc is expected to report earnings per share of -0.12 for the current quarter.
Nuvation Bio Inc (NYSE:NUVB) trade information
Instantly NUVB has been showing red trend so far today with a performance of -0.27% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.1900 on recent trading dayincreased the stock’s daily price by 16.89%. The company’s shares are currently down -31.77% year-to-date, but still down -8.33% over the last five days. On the other hand, Nuvation Bio Inc (NYSE:NUVB) is -20.04% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 74.0% from its current value. Analyst projections state that NUVB is forecast to be at a low of $7 and a high of $7.
Nuvation Bio Inc (NUVB) estimates and forecasts
Forecasts for the next quarter put sales growth at 0.00%.
Nuvation Bio Inc earnings are expected to increase by -514.29% in 2025, but the outlook is negative -18.34% per year for the next five years.
Nuvation Bio Inc (NYSE:NUVB)’s Major holders
ECOR1 CAPITAL, LLC, with 7.8491% or 19.21 million shares worth $56.09 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 13.83 shares worth $25.17 million, making up 4.11% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 6.13 shares worth around $11.15 million, which represents about 1.82% of the total shares outstanding.
